Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Virus Eradication
|
March 14, 2023
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a "single-shot" functional cure for HIV infection
Patricia A Hahn, Mauricio A Martins
Human Vaccines & Immunotherapeutics
|
May 22, 2026
Could AAV-vectored delivery of broadly neutralizing antibodies (bNAbs) reduce virologic failure in children diagnosed with perinatal HIV?
Kaiya L Pringle, Mauricio A Martins
Cold Spring Harbor Perspectives in Biology
|
March 29, 2017
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive
Mauricio A Martins, David I Watkins
Journal of Virology
|
August 14, 2015
Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing
Jennifer N Rainho, Mauricio A Martins, Francesc Cunyat, et al.
Journal of Virology
|
February 19, 2010
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge
Mauricio A Martins, Nancy A Wilson, Jason S Reed, et al.
Journal of Visualized Experiments : Jove
|
January 7, 2017
Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Lucas Gonzalez-Nieto, Aline Domingues, Michael Ricciardi, et al.
Journal of Virology
|
April 29, 2021
Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition
Isabelle M Castro, Michael J Ricciardi, Lucas Gonzalez-Nieto, et al.
Plos Pathogens
|
June 19, 2018
A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products
Young C Shin, Georg F Bischof, William A Lauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 16, 2019
Vaccine protection against SIVmac239 acquisition
Mauricio A Martins, Georg F Bischof, Young C Shin, et al.
Journal of Virology
|
February 10, 2012
The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages
Lara Vojnov, Mauricio A Martins, Alexander T Bean, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Virus Eradication
|
March 14, 2023
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a "single-shot" functional cure for HIV infection
Patricia A Hahn, Mauricio A Martins
Human Vaccines & Immunotherapeutics
|
May 22, 2026
Could AAV-vectored delivery of broadly neutralizing antibodies (bNAbs) reduce virologic failure in children diagnosed with perinatal HIV?
Kaiya L Pringle, Mauricio A Martins
Cold Spring Harbor Perspectives in Biology
|
March 29, 2017
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive
Mauricio A Martins, David I Watkins
Journal of Virology
|
August 14, 2015
Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing
Jennifer N Rainho, Mauricio A Martins, Francesc Cunyat, et al.
Journal of Virology
|
February 19, 2010
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge
Mauricio A Martins, Nancy A Wilson, Jason S Reed, et al.
Journal of Visualized Experiments : Jove
|
January 7, 2017
Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Lucas Gonzalez-Nieto, Aline Domingues, Michael Ricciardi, et al.
Journal of Virology
|
April 29, 2021
Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition
Isabelle M Castro, Michael J Ricciardi, Lucas Gonzalez-Nieto, et al.
Plos Pathogens
|
June 19, 2018
A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products
Young C Shin, Georg F Bischof, William A Lauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 16, 2019
Vaccine protection against SIVmac239 acquisition
Mauricio A Martins, Georg F Bischof, Young C Shin, et al.
Journal of Virology
|
February 10, 2012
The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages
Lara Vojnov, Mauricio A Martins, Alexander T Bean, et al.
Page
of 4